Patent Application
Provisional
App. No. 63/573,409
· Confirmation No. 5291
USE OF REBOXETINE TO TREAT NARCOLEPSY
Inventor:
Herriot Tabuteau
Applicant:
Axsome Therapeutics, Inc.
Provisional Application Expired
|
⬇ PDF
|
Code | Description | Pages | ||
|---|---|---|---|---|---|
| 2024-04-10 | APP.FILE.REC |
Filing Receipt | 3 | View | |
| 2024-04-10 | WELCOME.LET |
Welcome Letter from USPTO Director and Deputy Director | 1 | View | |
| 2024-04-02 | SPEC |
Specification | — | View | |
| 2024-04-02 | DRW |
Drawings-only black and white line drawings | 5 | View | |
| 2024-04-02 | N417 |
Electronic Filing System Acknowledgment Receipt | 3 | View | |
| 2024-04-02 | SPEC |
Specification | 102 | View | |
| 2024-04-02 | CLM |
Claims | 3 | View | |
| 2024-04-02 | ABST |
Abstract | 1 | View | |
| 2024-04-02 | N417.PYMT |
Electronic Fee Payment | 2 | View | |
| 2024-04-02 | ADS |
Application Data Sheet | 8 | View |
Inventors
Herriot Tabuteau
New York, NY
Attorneys & Agents of Record
Prosecution
- Customer No.
- 27189
- Docket No.
- 134057-00000536
- Confirmation No.
- 5291
No recorded assignments were found for this patent.
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
- App. No.
- 63/573,409
- Filed
- 2024-04-02
External Links